Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Dallas TX, Houston TX, Bellaire TX, Lubbock TX,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase 3, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Dallas TX, Houston TX, Germantown TN, Westwood KS,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Cytokinetics

Sex: All

Age: 40 - 70+

Code: NCT06793371

Phase 2, Recruiting

GammaPod Registry and Quality of Life Nomogram

for
Breast Cancer Female
Location: Dallas TX, Columbia MD, Glen Burnie MD, Bel Air MD
Sponsor: University of Maryland, Baltimore

Sex: Female

Age: 18+

Code: NCT03562273

Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Dallas TX, Austin TX, San Antonio TX, Fairway KS,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Dallas TX, Cincinnati OH, Goshen IN, Columbus OH
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase 1, Phase 2, Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

for
Cystic Fibrosis, Parenthood Status
Location: Dallas TX, Kansas City KS, St Louis MO, Birmingham AL,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06296394

Recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

for
Pulmonary Embolism
Location: Dallas TX, Birmingham AL, Knoxville TN, Tucson AZ,
Sponsor: Innova Vascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06041594

Recruiting

A Randomized Multicenter Study for Isolated Skin Vasculitis

for
Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa,
Location: Dallas TX, Kansas City KS, Charlottesville VA, Hamilton,
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT02939573

Phase 2, Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

for
Mycosis Fungoides, Non-Hodgkin's Lymphoma
Location: Dallas TX, Iowa City IA, Salt Lake City UT,
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT02848274

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for
B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins,
Location: Dallas TX, Salt Lake City UT, Cleveland OH,
Sponsor: Estrella Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT06343311

Phase 1, Phase 2, Recruiting

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

for
Cancer
Location: Irving TX, Franklin TN, Jacksonville FL
Sponsor: Center for Biomedical Research, LLC

Sex: All

Age: 0+

Code: NCT02070328

Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Fort Worth TX, Spring TX, Germantown TN, Kansas City MO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

for
Pancreas Cancer, Oligometastatic
Location: Dallas TX, Houston TX, Camden NJ, Voorhees Township NJ
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06593431

Phase 3, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase 2, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Dallas TX, Louisville KY, Duarte CA, Santa Monica CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase 1, Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Nashville TN, Cleveland OH, Orange CA,
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05361720

Phase 2, Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

for
Cystic Fibrosis Lung
Location: Dallas TX, Kansas City KS, Birmingham AL, Denver CO,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT05248230

Phase 2, Recruiting

Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries

for
Head Injuries, Closed
Location: Dallas TX, Houston TX, Toronto
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 0 - 12

Code: NCT00006128

Recruiting

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

for
Fatty Liver
Location: Dallas TX
Sponsor: Methodist Health System

Sex: All

Age: 18+

Code: NCT06225193

Recruiting